» Articles » PMID: 20103531

A Putative Role for MicroRNA-205 in Mammary Epithelial Cell Progenitors

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2010 Jan 28
PMID 20103531
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

In an effort to understand the potential role of microRNAs (miRNAs) in mammary-gland stem or progenitor cells, miRNA microarrays were performed on subpopulations of the mouse mammary epithelial cell (MEC) line COMMA-DbetaGeo. This cell line contains a heterogeneous subpopulation of progenitors characterized by the expression of stem cell antigen 1 (Sca-1; encoded by Ly6a). Microarray analysis indicated that the Sca-1 subpopulations have distinct miRNA expression profiles. Functional studies were performed on miR-205, which was highly expressed in the Sca-1-positive (Sca-1(+)) cells. When miR-205 was overexpressed in vitro, the COMMA-DbetaGeo cells underwent several significant morphological and molecular changes. miR-205 overexpression led to an expansion of the progenitor-cell population, decreased cell size and increased cellular proliferation. In addition, the colony-forming potential of the two Sca-1 subpopulations was increased. Target prediction for miR-205 indicated that it might regulate the expression of the tumor-suppressor protein PTEN. Overexpression studies using reporter constructs confirmed that PTEN expression is regulated by miR-205. In addition to PTEN, several other putative and previously validated miR-205 targets were identified by microarray analysis, including the previously reported miR-205 targets ZEB1 and ZEB2. Additionally, in normal mouse MECs, high expression of miR-205 was observed in stem-cell-enriched cell populations isolated by FACS using established cell-surface markers.

Citing Articles

Absolute Quantification of Selected microRNAs Expression in Endometrial Cancer by Digital PCR.

Bogaczyk A, Potocka N, Paszek S, Skrzypa M, Zuchowska A, Kosny M Int J Mol Sci. 2024; 25(6).

PMID: 38542261 PMC: 10969921. DOI: 10.3390/ijms25063286.


MicroRNA205: A Key Regulator of Cardiomyocyte Transition from Proliferative to Hypertrophic Growth in the Neonatal Heart.

Weldrick J, Yi R, Megeney L, Burgon P Int J Mol Sci. 2024; 25(4).

PMID: 38396885 PMC: 10889831. DOI: 10.3390/ijms25042206.


Genetic Loss of miR-205 Causes Increased Mammary Gland Development.

Cataldo A, Cheung D, Hagan J, Fassan M, Sandhu-Deol S, Croce C Noncoding RNA. 2024; 10(1).

PMID: 38250804 PMC: 10801544. DOI: 10.3390/ncrna10010004.


miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis.

Cheng J, Ho W, Wu B, Liu H, Lin W Sci Rep. 2023; 13(1):13805.

PMID: 37612427 PMC: 10447559. DOI: 10.1038/s41598-023-40879-y.


Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment.

Oropeza-de Lara S, Garza-Veloz I, Berthaud-Gonzalez B, Martinez-Fierro M Cancers (Basel). 2023; 15(10).

PMID: 37345024 PMC: 10216486. DOI: 10.3390/cancers15102686.


References
1.
Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

2.
He L, Thomson J, Hemann M, Hernando-Monge E, Mu D, Goodson S . A microRNA polycistron as a potential human oncogene. Nature. 2005; 435(7043):828-33. PMC: 4599349. DOI: 10.1038/nature03552. View

3.
Gottardo F, Liu C, Ferracin M, Calin G, Fassan M, Bassi P . Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007; 25(5):387-92. DOI: 10.1016/j.urolonc.2007.01.019. View

4.
Wang X, Tang S, Le S, Lu R, Rader J, Meyers C . Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One. 2008; 3(7):e2557. PMC: 2438475. DOI: 10.1371/journal.pone.0002557. View

5.
Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M . miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res. 2009; 69(6):2287-95. DOI: 10.1158/0008-5472.CAN-08-2894. View